PubMed

Survivor costs in cost-effectiveness analysis.

Gandjour A.

Ann Intern Med. 2006 Apr 4;144(7):534-5; author reply 535. No abstract available. PMID: 16585672 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.

Schonfeld W, Wang Cheng J, Tong KB, Seifeldin R.

Clin Ther. 2008 May;30(5):964-73.PMID: 18555943 [PubMed - indexed for MEDLINE]Related articles

Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.

Ament AJ, Hübben MW, Verweij PE, de Groot R, Warris A, Donnelly JP, van 't Wout J, Severens JL.

J Antimicrob Chemother. 2007 Aug;60(2):385-93. Epub 2007 Jun 7.PMID: 17561501 [PubMed - indexed for MEDLINE]Related articlesFree article

[Cost-effectiveness analysis of the empirical antifungal strategy in oncohaematological patients]

Romá-Sánchez E, Poveda-Andrés JL, García-Pellicer J, Salavert-Lletí M, Jarque-Ramos I.

Farm Hosp. 2008 Jan-Feb;32(1):7-17. Spanish. PMID: 18426697 [PubMed - indexed for MEDLINE]Related articlesFree article

Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany.

Cornely OA, Sidhu M, Odeyemi I, van Engen AK, van der Waal JM, Schoeman O.

Curr Med Res Opin. 2008 Jun;24(6):1743-53. Epub 2008 May 9.PMID: 18477422 [PubMed - indexed for MEDLINE]Related articles

The answer is in: fluconazole prophylaxis is not beneficial for intensive care unit patients without neutropenia.

Fekete T.

Ann Intern Med. 2008 Jul 15;149(2):140-1. No abstract available. PMID: 18626054 [PubMed - indexed for MEDLINE]Related articlesFree article

[Cost-effectiveness of empirical antifungal treatment of haematology patients with a high risk of invasive fungal infection]

Espigado I.

Farm Hosp. 2008 Jan-Feb;32(1):4-6. Spanish. No abstract available. PMID: 18426696 [PubMed - indexed for MEDLINE]Related articlesFree article

Nosocomial candidemia: an ounce of prevention is better than a pound of cure.

Diekema DJ, Pfaller MA.

Infect Control Hosp Epidemiol. 2004 Aug;25(8):624-6. No abstract available. PMID: 15357151 [PubMed - indexed for MEDLINE]Related articles

Combination treatment of candidal fingernail onychomycosis.

Thomas CL.

Br J Dermatol. 2004 Jun;150(6):1227; author reply 1227-8. No abstract available. PMID: 15214929 [PubMed - indexed for MEDLINE]Related articles

Echinocandins for candidemia in adults without neutropenia.

Bennett JE.

N Engl J Med. 2006 Sep 14;355(11):1154-9. Review. No abstract available. PMID: 16971721 [PubMed - indexed for MEDLINE]Related articles

Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?

Garbino J, Schnetzler G, Roberts C.

Swiss Med Wkly. 2006 Sep 30;136(39-40):624-30.PMID: 17086508 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimizing therapy for Candida infections.

Playford EG, Sorrell TC.

Semin Respir Crit Care Med. 2007 Dec;28(6):678-88. Review.PMID: 18095232 [PubMed - indexed for MEDLINE]Related articles

Reply: Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.

Huprikar S.

Liver Transpl. 2008 May;14(5):709. No abstract available. PMID: 18433053 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.

de Vries R, Daenen S, Tolley K, Glasmacher A, Prentice A, Howells S, Christopherson H, de Jong-van den Berg LT, Postma MJ.

Pharmacoeconomics. 2008;26(1):75-90.PMID: 18088160 [PubMed - indexed for MEDLINE]Related articles

[Invasive candidiasis in the critically ill, patient non-neutropenic]

Schwetz I, Domej W, Krause R.

Wien Med Wochenschr. 2007;157(19-20):490-2. Review. German. PMID: 18030553 [PubMed - indexed for MEDLINE]Related articles

[Bloodstream Candida infections]

Izvekova IIa.

Antibiot Khimioter. 2007;52(4-5):30-42. Review. Russian. PMID: 18464563 [PubMed - indexed for MEDLINE]Related articles

Invasive Candida species infection: the importance of adequate empirical antifungal therapy.

Armstrong-James D.

J Antimicrob Chemother. 2007 Sep;60(3):459-60. Epub 2007 Jul 23.PMID: 17646200 [PubMed - indexed for MEDLINE]Related articlesFree article

Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results.

Van Campenhout H, Marbaix S, Derde MP, Annemans L.

Clin Drug Investig. 2008;28(8):509-21.PMID: 18598097 [PubMed - indexed for MEDLINE]Related articles

Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study.

Garey KW, Turpin RS, Bearden DT, Pai MP, Suda KJ.

Int J Antimicrob Agents. 2007 May;29(5):557-62. Epub 2007 Mar 6.PMID: 17341444 [PubMed - indexed for MEDLINE]Related articles

Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.

Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, Venezia RA.

J Clin Microbiol. 2006 Sep;44(9):3381-3.PMID: 16954279 [PubMed - indexed for MEDLINE]Related articlesFree article